How to seek launch excellence in China

China may offer a dynamic market for drug companies, but the country’s changeable policies and unique healthcare insurance system are among the major challenges faced by companies seeking launch excellence, reports The Pharma Letter’s local correspondent, Wang Fangqing.

What could be the proper approach? In short, plan early and have vision, according to Zhu Liliang, director of management consulting at IQVIA.

“Planning should start as early as in the pre-clinical stage. Some key points you have to think over include the indications, your target, and your stakeholders,” Ms Zhu said.